Project Details
Cancer Drug Target Discovery
The project achieved a breakthrough progress in the discovery of novel drug targets of high value, it is expected to produce a large number of new patent anticancer drugs.
Related items
Cooperation with the National Metrology Institute of Technology project, standard technology projects with international top level standard based on a high level of metrological traceability and biological ion simulation and preparation techniques.
This project uses a patented nano-chip technology worldwide, creating a possible new rapid high-throughput immunodiagnostics, clinical diagnosis will have a significant impact, especially revolutionary in the POCT diagnosis of malignancy.
生命谷与创业工场孵化项目。 创新型的超大型复杂流体诊断系统研发企业。
美中药源 健通生物创始团队为国际大型制药集团的资深专家,拥有丰富新药研发经验和多年的合作经历,以及生物制药行业世界一流专家及人脉资源。健通生物主要包括《美中药源》专业网站、美中E药源精准用药平台、医药转化平台三个板块。
More Projects
Home
About Us
News
Information
Investment
Jobs
Contact
Incubation Project
Company Profile
Philosophy
Areas of concern
Business
Entrusted investment
 
Industry News
Industry Information
Investment Advantages
Principal investment
Talent Concept
Careers
Shenzhen Sangel Venture Capital Co.,Ltd
Address:Room 2401/2402, Shenzhen Bay VC&PE Builing, Nanshan District, Shenzhen,Guangdong Province, China 
Tel:0755-26069007
Fax:0755-26491800
Website:www.sangelvc.com

Copyright © 2008-2016 | All Rights Reserved | Shenzhen Sangel Venture Capital Co.,Ltd. | ICP:15012769